Ratings Healwell AI Inc. Deutsche Boerse AG

Equities

6H90

CA42249X1006

Real-time Estimate Tradegate Other stock markets 13:37:54 26/06/2024 BST			5-day change	1st Jan Change
1.53 ^EUR	-5.56%		-15.72%	+223.96%

06-13	Healwell AI Agrees to Buy BioPharma Services For $11.9 Million to Expand Clinical Research Offerings	MT
06-13	Healwell AI Inc. agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.	CI

Strengths

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the past twelve months, EPS forecast has been revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
HEALWELL AI INC.	+223.96%	226M	-	-
AIER EYE HOSPITAL GROUP CO., LTD.	-32.87%	13.37B		B+
IHH HEALTHCARE	+4.15%	11.75B		B+
BANGKOK DUSIT MEDICAL SERVICES	-3.60%	11.57B		B
APOLLO HOSPITALS ENTERPRISE LIMITED	+7.59%	10.85B		B+
ENCOMPASS HEALTH CORPORATION	+27.20%	8.55B		B
RAMSAY HEALTH CARE LIMITED	-11.44%	7.24B		A-
THE ENSIGN GROUP, INC.	+7.99%	6.84B		B-
MOUWASAT MEDICAL SERVICES COMPANY	+8.77%	6.5B		D
CONCORD HEALTHCARE GROUP CO., LTD.	0.00%	4.4B	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes